Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

CareFusion and Blue Cross and Blue Shield of Illinois Create Illinois Hospital Quality Initiative to Help Eliminate Health Care-Associated Infections

September 15, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 15 /- CareFusion and Blue Cross and Blue Shield of Illinois today announced that 23 hospitals have formed the Illinois Hospital Quality Initiative (IHQI), a partnership created to improve clinical outcomes and cut health care costs by reducing health care-associated...

Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 14 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at UBS' Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. ET at the Grand Hyatt New...

Quinton Oswald Named Chief Executive Officer of SARcode Corporation

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Sept. 14 /- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced that Quinton Oswald has joined the company as Chief Executive Officer. Mr. Oswald...

Advertisement

TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

READING, Pa. and RALEIGH, N.C., Sept. 14 /- TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center (TRHMC). The 671-bed hospital chose...

Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Sept. 14 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at the following investor conferences: The CL King 8th Annual Best Ideas Conference to be held September 15-16, 2010 at the Omni Berkshire Place Hotel in New York City....

ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...

RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti

September 13, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Sept. 13 /- RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ).  The L-Ti was previously cleared as an interbody fusion device. RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about...

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015

September 13, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015 -- DALLAS, September 13, 2010 /-

Advertisement

Siemens and National Semiconductor Align to Advance Ultrasound Technology

September 13, 2010 5:37 am | News | Comments

Siemens Medical Solutions USA, Inc. and National Semiconductor Corporation announce a wide-ranging strategic alliance to advance ultrasound technology, creating ultrasound imaging systems...

Debiopharm Group™ and Aurigene Nominate Development Candidate

September 13, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

LAUSANNE, Switzerland, and BANGALORE, India, Sept. 13 /- Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies...

Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents

September 10, 2010 5:36 pm | by Covidien | News | Comments

ST. LOUIS, Sep 10, 2010 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or...

Covance to Present at Morgan Stanley Global Healthcare Conference

September 10, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept. 10 /- Covance Inc. (NYSE: CVD ) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 p.m. ET.  Investors may access a live webcast of the presentation at www.covance.com .  In order...

FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women

September 10, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

WILMINGTON, Del., Sept. 10 /- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection , replacing the previously approved monthly dose of 250mg, for the treatment of hormone...

Advertisement

Massachusetts Regional Extension Center Selects Greenway's PrimeSuite

September 9, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

CARROLLTON, Ga., Sept. 9 /- The Massachusetts e-Health Institute, a division of the Massachusetts Technology Collaborative, has selected Greenway Medical Technologies, Inc.'s single-database electronic health record (EHR), practice management and interoperability solution PrimeSuite®...

New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting

September 9, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 9 /- Live video detailing has made a strong comeback after a false start in the early 2000s, according to pharmaceutical and healthcare market research company Manhattan Research's ePharma Physician ® v10.0 study. Physician adoption of live video detailing has more...

Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection

September 9, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Sept. 9 /- Medizone International, Inc. (OTC Bulletin Board, OTCQB: MZEI) announces it has filed an additional international patent application covering recent developments in its variant of AsepticSure™ designed for government use in bio-terrorism countermeasures....

Misonix Announces New Distribution Agreement For Spain

September 9, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Sept. 9 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Dismeval, s.l.,  based in...

Streamline Health Document Workflow Solutions Purchased By Tampa, Florida-Based Hospital

September 8, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Sept. 8 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of...

Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics

September 8, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 8 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the...

NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel

September 7, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Sept. 7 /- NetMotion Wireless, a leading provider of mobile productivity and management software, announced today that its award winning mobile Virtual Private Network (VPN) solution, Mobility XE, has been deployed by IDEXX to improve the performance of hundreds of mobile workers...

DSM Launches InnoSyn™ Route Scouting Services to Meet Pharmaceutical Company Needs to Outsource R & D

September 7, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Sept. 7 /- DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost...

Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports

September 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to... -- DALLAS, September 6, 2010 /-

New and Unique Tool Eases the Process of Finding Article Reviewers

September 6, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

New and Unique Tool Eases the Process of Finding Article Reviewers -- AMSTERDAM, September 6, 2010 /-

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders

September 6, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming......

Property Sales Give Biotech Brokers the Jitters

September 5, 2010 11:32 pm | by San Diego Business Journal | News | Comments

Experts say the recently announced purchase of three San Diego life sciences buildings by Alexandria Real Estate Equities Inc., already among the dominant players in local biotech real estate, marks a continuing trend toward consolidation, and could also signal a spree of acquisitions...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading